BARCLAYS PLC (BCS): what the price assumes

Generated: 2026-07-24 · Exported: 2026-07-25 · Source: https://boothcheck.com/report/BCS

Headline

Field	Value
Ticker	BCS
Company	BARCLAYS PLC
Sector / Industry	Financial Services
Current price	$28.03/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Field	Value
Inversion basis	financials
Price-to-book	1.15x
Return on equity now	11.0%

The implied return on book is non-physical at this price-to-book and is suppressed as misleading. The price sits beyond a 11.7% return on equity sustained for 40 years and is not resolvable as a sustainable-ROE point. The rarity read below is the honest signal.

Solve inputs: computed at a 11.8% cost of equity; ROE searched up to the 11.7% ROE ceiling.

Reconcile: at the x-ray's 9.3% required return this reads ~10%; the models below use their own rates.

How unusual the bet is: extreme

Reference	Value
vs own history	+1.58σ
cohort percentile (of 162 peers)	27
sustained it ~10 years at this level	67%
implied end-window share	0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Family	Median price/FV	Models	Reads
Asset	1.00x	3	justifies
Earnings	0.95x	2	justifies
Relative	1.05x	3	expensive
Growth	0.69x	1	justifies

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 2.5%); the inversion above states its own rate.

Per-Model Detail (n=9)

Model	Family	FV	Price/FV	Applicable	Methodology
DCF Perpetual Growth	Growth	—	—	no	—
Bank Fair Value (P/TBV)	—	$26.30	1.07x	yes	TBVPS $26.49 × 0.99x (ROE (TTM) 9.2% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative Valuation	Relative	$31.10	0.90x	yes	P/E 10x (static sector reference · 2026-04), scenarios: 8.0x / 10.0x / 12.0x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDM	Growth	—	—	no	—
Two-Stage DDM	Growth	—	—	no	—
Simple Excess Return	Asset	$27.98	1.00x	yes	BV/sh $28.07, ROE (TTM) 9.2%, ke 9.3%
Two-Stage Excess Return	Asset	$27.93	1.00x	yes	5yr excess ROE then converge to ke=9.3%
Discounted Future Market Cap	Growth	$40.66	0.69x	yes	Rev $45.8B, growth 30% (input: historical growth; tapered), Terminal P/S: 1.7x / 2.2x / 2.6x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair Value	Relative	$26.61	1.05x	yes	EPS $2.22, growth 6% (input: historical EPS growth), PEG=1.83 (Overvalued)
Margin Trajectory	Growth	—	—	no	—
Earnings Power Value	Earnings	—	—	no	—
Residual Income	Asset	—	—	no	—
Graham Number	Asset	$37.43	0.75x	yes	√(22.5 × EPS $2.22 × BVPS $28.07) — Graham's conservative floor
EV/EBITDA Relative	Relative	—	—	no	—
FCF Yield	Earnings	—	—	no	—
SBC-Adj FCF Yield	Earnings	—	—	no	—
Ben Graham Formula	Earnings	$37.82	0.74x	yes	EPS $2.22 × (8.5 + 2×5.9%) × (4.4 / 5.3%)
ROIC-Justified P/B	Asset	—	—	no	—
P/Sales Sector	Relative	—	—	no	—
PEG Fair Value	Relative	$19.71	1.42x	yes	EPS $2.22 × (PEG 1.5 × growth 5.9% (input: historical EPS growth)) → PE 8.9x
Earnings Yield	Earnings	$23.98	1.17x	yes	EPS $2.22 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations Multiple	Relative	—	—	no	—
Clinical Phase NPV	Growth	—	—	no	—
Merton	Asset	—	—	no	—
V5 Mechanical	—	—	—	no	—

Solvency

Field	Value
Share count CAGR (buyback)	-4.5%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

• Every division earned a double-digit return in the first quarter of 2026, led by the private bank and wealth arm at 25.5% and the UK ring-fenced bank at 19.7%, while the investment bank cleared £4.028bn of income.

• The bet the price makes is that a return on equity near 13% becomes normal for this bank, against the roughly 11% return on equity it has been earning lately.

• Half-year results land on July 28, 2026, the first check on management's stated path to a return on tangible equity above 12% for 2026 and above 14% by 2028.

Bull Case

The interesting thing about Barclays in 2026 is that the argument has stopped being about one division rescuing the others. In the first quarter, the UK ring-fenced bank returned 19.7% on tangible equity, the UK corporate bank 19.9%, the US consumer bank 18.8%, the private bank and wealth business 25.5%, and the investment bank 15.0%. Group income rose 6% to £8.163bn and profit before tax reached £2.814bn. A bank where every reported unit clears its own cost of capital is a different proposition from one where a good markets quarter papers over a weak retail franchise.

The investment bank is the piece the market has always struggled to pay for, and it is the piece that has changed most. Quarterly income of £4.028bn on a 15.0% return is not the trading-desk lottery ticket of the past decade; it is a franchise earning an acceptable return on the capital tied up in it. That matters because the discount applied to Barclays has historically been a discount applied to the investment bank specifically.

Costs and credit are both behaving. The cost to income ratio improved to 56% from 57%, and the impairment charge of £823m equated to a loan loss rate of 74 basis points, a level that reflects the US card book rather than any deterioration in the UK. Capital finished the quarter at a CET1 ratio of 14.1%, and at 13.9% including the newly announced buyback, which management describes as the top of its 13% to 14% target range.

What that capital position funds is the clearest part of the case. Barclays announced a further £500m repurchase on completion of a £1bn programme, and has committed to returning at least £10bn to shareholders across 2024 to 2026 and more than £15bn across 2026 to 2028. The effect is already visible where it cannot be dressed up: the share count has fallen at roughly four and a half percent a year since 2021. Buying back a bank's own stock near book value adds directly to per-share tangible assets, and it does so at a faster rate the cheaper the shares are.

Management has put dates and numbers on the rest. Group net interest income excluding the investment bank and head office is guided above £13.5bn for 2026, with the UK bank contributing £8.1bn to £8.3bn, and the return targets are a group return on tangible equity above 12% this year and above 14% in 2028. The bear will say targets are cheap to publish. The counter is that this management team has been publishing them for three years against a plan the market did not believe, and the divisional returns above are what the plan looks like when it is working.

Bear Case

Start with what the price is asking for. At today's quote the market needs this bank to earn a return on equity of about 13% and to keep earning it, against roughly 11% lately. That gap looks small. It is not, because a bank's valuation is a lever on that number: if the return settles back toward what has actually been earned, the price to book the shares can support compresses with it, and there is no growth story underneath to cushion the compression.

The reconciliation matters here and cuts against the bull. The headline 13.5% the bank reported for the first quarter is measured on tangible equity, which strips out goodwill and intangibles. Measured on the whole equity base that shareholders actually own, the return is lower, and it is the whole equity base the price is buying. Two very different numbers describe the same quarter, and the flattering one is the one that gets into the headline.

Against the domestic peer group the shortfall is plainer still. NatWest reported a 18.2% return on tangible equity in the first quarter of 2026 and Lloyds 17.0%, both well ahead of Barclays. That is the whole reason the shares trade in the lower half of the peer group on price to book. The discount is not an oversight the market will eventually correct; it is a judgment about the earnings mix, and the earnings mix is the issue.

That mix is roughly half an investment bank. Markets and banking income is the least predictable revenue in financial services, and a quarter that produces £4.028bn of it can be followed by one that does not. The first-quarter return on tangible equity fell to 13.5% from 14.0% a year earlier even as income grew, which is what happens when the capital base expands more quickly than the profit it supports.

Credit is the other exposure and it points at America. The £823m impairment charge and a 74 basis point loan loss rate are carried disproportionately by the US consumer card business. Card losses are the most cyclical thing on a bank's balance sheet, they move fast when unemployment moves, and a US card book is a long way from the ring-fenced UK deposits that make the group look defensive.

Finally, the return targets themselves set the trap. Management has told the market to expect a return on tangible equity above 12% this year and above 14% by 2028. Publishing a multi-year return target converts every quarterly print into a scorecard. Miss twice and the credibility of the plan, not just the earnings, is what reprices.

Valuation

At $28.03 on July 24, 2026, each American depositary share represents a claim on a bank trading at about 1.15 times its book value. That is the whole valuation statement for a business like this: a bank is worth the return it earns on the capital it holds, so the price is read off book, never off an operating multiple. What the price asks for is a return on equity near 13%, against roughly 11% lately, and it asks for it indefinitely rather than for a run of good quarters.

On that point the report's own arithmetic and the bank's headline disagree in a way worth naming. Barclays reported a 13.5% return on tangible equity for the first quarter of 2026. Tangible equity excludes goodwill and intangibles, so it is a smaller denominator and a flattering one; the return on the full equity base that the share price buys is lower. Both numbers are correct. Only one of them is what a buyer at this price is underwriting.

The methods used to triangulate value cluster tightly, which is itself the finding. Book value plus profitability lands almost exactly at the price. Peer multiples put the price about 5% above where they land; the earnings-power lenses put it about 5% below. Only the forward-looking method sits meaningfully higher, leaving the price about 31% below where it lands. A spread that narrow says the market is not paying a premium for a story here. It is paying roughly what the balance sheet and the current earnings support, and the debate is confined to whether those earnings persist.

Cohort position sharpens it. On price to book the shares sit in the lower half of the peer group, which is consistent with the first-quarter returns at NatWest and Lloyds of 18.2% and 17.0% against Barclays at 13.5%. The discount is earned, and it closes only if the returns converge.

The balance sheet frame for a bank is capital and payout rather than leverage and coverage, and both read comfortably. CET1 finished the first quarter at 14.1%, or 13.9% after the new buyback, at the top of the stated 13% to 14% range, with an impairment charge of £823m and a loan loss rate of 74 basis points. Against that, more than £15bn of returns are planned across 2026 to 2028. A bank buying back roughly four and a half percent of its shares a year just above book value is compounding tangible book per share whether or not the return on equity ever reaches what the price assumes, which is the most concrete support under this valuation.

Catalysts

The near date is fixed: half-year results on July 28, 2026, with the chief executive and finance director hosting the call that morning. It is the first full check on the 2026 targets, and the specific lines to watch are group net interest income excluding the investment bank and head office, guided above £13.5bn, and the UK bank's contribution of £8.1bn to £8.3bn.

Capital returns are the second thread and the most mechanical. A £500m repurchase was announced with the first-quarter results on completion of the prior £1bn programme, inside a commitment to return at least £10bn across 2024 to 2026 and more than £15bn across 2026 to 2028. Each half-year announcement is where the next tranche gets sized, and with CET1 at 14.1% before the buyback and 13.9% after it, the capital to fund one is visibly there.

The slower-moving item is the return target itself. Management has guided to a group return on tangible equity above 12% in 2026 and above 14% in 2028. The first quarter came in at 13.5%, ahead of the near-term target and behind the longer one, so each print between now and then is a data point on whether the trajectory bends up or flattens. The credit line underneath deserves equal attention: a 74 basis point loan loss rate driven by the US card book is the number most likely to move first if the American consumer slows.

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Barclays Q1 2026 results · NatWest Group Q1 2026 results; Lloyds Banking Group Q1 2026 interim management statement · NatWest Group Q1 2026 results; Lloyds Banking Group Q1 2026 interim management statement; Barclays Q1 2026 results · Barclays financial calendar